JO
WHWK

John Overdeck’s Whitehawk Therapeutics WHWK Stock Holding History

John Overdeck’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
296,612
+23,130
+8% +$96.2K ﹤0.01% 3366
2026
Q1 		$944K Sell
273,482
-36,383
-12% -$114K ﹤0.01% 3304
2025
Q4 		$750K Buy
+309,865
New +$711K ﹤0.01% 3099
2025
Q2 		– Sell
-43,158
Closed -$76.8K – 3657
2025
Q1 		$76.8K Sell
43,158
-25,397
-37% -$66.3K ﹤0.01% 2993
2024
Q4 		$216K Buy
68,555
+51,638
+305% +$117K ﹤0.01% 2852
2024
Q3 		$34.8K Buy
+16,917
New +$27.3K ﹤0.01% 2987
2020
Q4 		– Sell
-2,633
Closed -$59K – 3853
2020
Q3 		$59K Buy
+2,633
New +$55.4K ﹤0.01% 2971
2020
Q2 		– Sell
-1,142
Closed -$9K – 3627
2020
Q1 		$9K Sell
1,142
-1,993
-64% -$18.4K ﹤0.01% 2991
2019
Q4 		$29K Sell
3,135
-600
-16% -$5K ﹤0.01% 3586
2019
Q3 		$38K Sell
3,735
-747
-17% -$8.28K ﹤0.01% 3362
2019
Q2 		$61K Buy
+4,482
New +$68K ﹤0.01% 3236

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

John Overdeck's WHWK Position: Q2 2026 in Review

John Overdeck increased its Whitehawk Therapeutics (WHWK) stake by 8.5% in Q2 2026, buying an estimated $96.2K and bringing the position to 296,612 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

John Overdeck first reported a position in WHWK in Q2 2019 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • John Overdeck held 296,612 shares of Whitehawk Therapeutics worth $1.36M as of Q2 2026.
  • John Overdeck bought 23,130 Whitehawk Therapeutics shares in Q2 2026, an estimated $96.2K.
  • Whitehawk Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3366 holding.
  • John Overdeck first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.